NFKB1 and neoplasm: Activation of canonical NF-κB activation during KSHV infection promotes viral latency and survival for KSHV-infected cells [40], [41], and previously published data indicate that inhibition of SphK2 suppresses NF-κB activation in tumor cell lines [15], [31]–[33].